IPHA vs GILD: Which Stock is Better?
Side-by-side comparison of Innate Pharma Sa and Gilead Sciences Inc in 2026
IPHA
Innate Pharma Sa
$1.69
GILD
Gilead Sciences Inc
$139.77
Key Metrics Comparison
| Metric | IPHA | GILD | Winner |
|---|---|---|---|
| Market Cap | $152.94M | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -0.5% | 0.0% | GILD |
| Gross Margin | -384.4% | 78.8% | GILD |
Analyze IPHA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IPHA or GILD a better investment?
Comparing IPHA and GILD: Innate Pharma Sa has a market cap of $152.94M while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IPHA and GILD?
IPHA (Innate Pharma Sa) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IPHA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IPHA or GILD?
GILD has higher revenue growth at 0.0% vs -0.5% for IPHA.
Which company is more profitable: IPHA or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -384.4% for IPHA.
Which is the larger company: IPHA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $152.94M for IPHA.
Should I buy IPHA or GILD in 2026?
Both IPHA and GILD have investment merit. IPHA trades at $1.69 while GILD trades at $139.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IPHA and GILD stock?
Key differences: Market Cap ($152.94M vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (-0.5% vs 0.0%), Gross Margin (-384.4% vs 78.8%).